Tagrisso 80 mg is an oral prescription medicine containing osimertinib. It is a targeted anticancer treatment used in specific clinical settings involving non-small cell lung cancer (NSCLC) with certain epidermal growth factor receptor (EGFR) mutations.
Taking Tagrisso correctly involves following the prescribed dose, maintaining the recommended schedule, understanding the product’s administration instructions and attending regular medical appointments. Patients should also know how to respond to missed doses, possible side effects and changes in their health.
This guide provides general educational information. Always follow the instructions provided by your prescribing healthcare professional and the current patient leaflet supplied with your specific product.
1. Follow Your Prescribed Dose
The usual adult regimen described in official prescribing information for applicable indications is 80 mg taken orally once daily. However, the appropriate regimen depends on the patient’s diagnosis, treatment setting, clinical circumstances and any dose modifications recommended by the treating clinician.
Patients should check the prescription label before taking the medicine. If the prescribed instructions differ from general information on this website, contact the prescribing clinician or pharmacist to clarify the correct regimen.
Do not increase the dose because symptoms have not improved, take extra tablets to accelerate treatment or reduce the dose without professional guidance. Changes to the regimen must be based on an appropriate clinical assessment.
2. Take Tagrisso According to a Consistent Schedule
Following the prescribed schedule helps patients maintain an organized treatment routine. Taking the medicine at a consistent time each day may make it easier to remember the dose.
Patients can use a medication record, calendar or reminder system to support adherence. They should follow the instructions provided with the medicine and confirm the correct timing with a pharmacist if they are uncertain.
If the prescribed schedule becomes difficult to follow because of work, travel, sleep changes or other circumstances, discuss practical options with the healthcare team rather than changing the schedule independently.
3. Should Tagrisso Be Taken With Food?
Patients should follow the food-related instructions in the current official patient leaflet for their specific product. They should not assume that instructions for another cancer medicine apply to osimertinib.
If the leaflet is unavailable or unclear, ask the pharmacist or prescribing clinician whether the medicine should be taken with food or on an empty stomach.
Maintaining a consistent administration routine may help with adherence, but the exact food instructions should come from the applicable product information rather than general assumptions.
4. How to Take the Tablet
Take Tagrisso according to the administration instructions provided with the prescribed product. Check the medicine name and strength before taking each dose, particularly if more than one medicine is stored in the same area.
Do not use tablets that appear damaged or whose identity is uncertain. Keep the medicine in its recommended packaging when required and follow the supplied storage instructions.
If swallowing tablets is difficult, ask the healthcare professional or pharmacist for advice about the approved administration method. Do not crush, split or alter the tablet unless the current product instructions specifically permit the method.
5. What If You Miss a Dose?
If you miss a dose, follow the missed-dose instructions in the official patient leaflet. Do not take an extra or double dose to compensate.
If you cannot determine what to do, contact your pharmacist or oncology team for guidance. The appropriate next step may depend on the timing of the missed dose and the specific product instructions.
If missed doses occur repeatedly, tell your healthcare team. They may help identify practical barriers to taking the medicine consistently and discuss safe ways to manage the routine.
6. What If You Vomit After Taking Tagrisso?
If vomiting occurs after taking a dose, do not automatically take another tablet. Consult the current patient leaflet or contact your healthcare professional for instructions.
Taking an additional tablet without guidance could result in taking more medicine than prescribed. Patients should record what happened and follow the advice provided by their healthcare team.
If vomiting is persistent, severe or associated with an inability to maintain fluids, seek medical advice promptly.
7. Do Not Stop Treatment Without Medical Advice
Patients should not discontinue Tagrisso simply because they feel better or because symptoms have improved. The appropriate duration of treatment depends on the indication, treatment response, tolerability and the clinician’s plan.
Some patients may need a temporary interruption, dose modification or discontinuation because of adverse reactions or other clinical considerations. These decisions should be made by the treating healthcare professional according to the applicable prescribing information.
If treatment has been interrupted or the patient has run out of medicine, contact the oncology team or dispensing pharmacy for advice about the next steps. Do not restart or modify the regimen independently.
8. Understand Common Side Effects
Commonly reported side effects of osimertinib include diarrhea, skin rash, dry skin, nail changes and inflammation of the mouth.
Patients should tell their healthcare team about persistent or worsening symptoms, especially if they interfere with eating, drinking, sleeping or daily activities. Diarrhea may lead to dehydration if severe or prolonged, while worsening skin reactions or mouth sores may require additional care.
The healthcare professional can assess symptoms and recommend appropriate management. Patients should not start additional medicines, herbal products or supplements for side effects without checking their suitability.
9. Recognize Serious Warning Symptoms
Osimertinib can cause serious adverse reactions, including interstitial lung disease or pneumonitis, QT prolongation, cardiomyopathy, keratitis and aplastic anemia.
Seek prompt medical assessment for new or worsening shortness of breath, persistent cough, significant eye pain, visual changes, fainting or a rapid or irregular heartbeat. Severe or rapidly worsening symptoms may require emergency medical assistance.
Patients should not wait for a routine appointment if symptoms may indicate a serious reaction. They should follow the advice of the healthcare professional regarding any treatment interruption or other action.
10. Tell Your Doctor About Other Medicines
Before starting Tagrisso, provide the healthcare team with a complete list of medicines and supplements. This should include prescription medicines, nonprescription products, vitamins and herbal remedies.
Some medicines may affect heart rhythm or create overlapping safety risks. The clinician or pharmacist can assess potential interactions and determine whether additional monitoring or precautions are appropriate.
Do not start, stop or change another medicine solely because of information on a website. Consult a qualified professional before making changes to your medication regimen.
11. Attend Follow-Up Appointments
Regular follow-up is an important part of treatment. The oncology team evaluates whether the medicine is providing the intended benefit and whether adverse reactions require attention.
Depending on the clinical situation, monitoring may include symptom review, imaging, laboratory testing, electrocardiography or assessment of heart function.
Patients should attend scheduled appointments and inform the healthcare team about changes in their health, missed doses, new medicines and any difficulty following the treatment plan.
12. Pregnancy and Breastfeeding Considerations
Osimertinib may cause fetal harm. Patients who are pregnant, planning pregnancy or who think they may be pregnant should contact their oncology team promptly.
The healthcare professional should explain the applicable pregnancy-prevention precautions and contraception requirements using the current official prescribing information.
Breastfeeding also requires medical guidance because the medicine may pose risks to a nursing infant. Patients should discuss the applicable precautions with their healthcare team before starting treatment or changing their feeding plans.
13. Store Tagrisso Correctly
Store the medicine according to the instructions on the product packaging and patient leaflet. Keep it away from children and check the expiry date before use.
Do not take expired tablets or medicine whose identity or condition is uncertain. If the packaging is damaged, appears tampered with or may have been exposed to unsuitable storage conditions, ask the pharmacist for advice before using the product.
Product appearance alone cannot prove authenticity. Obtain prescription medicines through legitimate supply channels.
14. Tips for Managing Your Daily Treatment Routine
A few practical habits may help patients follow their prescribed regimen:
- Keep a written record of doses taken, if helpful.
- Use a daily reminder that fits your routine.
- Store the medicine according to its packaging instructions.
- Keep your prescription and medication list available for appointments.
- Plan ahead when traveling so that you can follow the prescribed schedule.
- Report side effects and missed doses to your healthcare team.
- Ask for clarification whenever the prescription or patient leaflet is unclear.
These habits can support adherence but do not replace professional advice or the instructions supplied with the medicine.
Frequently Asked Questions About Taking Tagrisso 80 mg
Can I take Tagrisso at any time of day?
Follow the schedule specified by your prescribing healthcare professional and product instructions. A consistent routine may help with adherence, but the exact timing should follow your prescription.
Can I take two tablets if I miss a dose?
Do not double the dose. Follow the missed-dose instructions in the current patient leaflet or contact your pharmacist for guidance.
Can I change my dose if I develop side effects?
Do not change the dose independently. Contact your healthcare team, which can assess the symptoms and determine whether treatment modification is appropriate.
What should I do if I am unsure whether I took my dose?
Do not take an additional tablet simply because you are uncertain. Contact your pharmacist or healthcare team for advice based on the product instructions and circumstances.
Can I take supplements while using Tagrisso?
Discuss supplements, vitamins and herbal products with your healthcare professional before use. Their safety and potential interactions should be assessed individually.
What if I run out of Tagrisso?
Contact your dispensing pharmacy or oncology team as soon as possible to discuss the supply issue and appropriate next steps. Do not substitute another medicine or change the regimen without professional advice.
Conclusion
Taking Tagrisso 80 mg correctly requires following the prescribed dose and schedule, checking the product-specific administration instructions, managing missed doses appropriately and maintaining regular contact with the oncology team.
Patients should report side effects early, disclose all medicines and supplements, attend monitoring appointments and seek urgent assessment for serious symptoms. Clear communication with the healthcare team helps support safer and more consistent treatment.
Medical Disclaimer: This page provides general educational information and does not replace medical advice, diagnosis, treatment or official prescribing information. Dosage, administration and treatment changes must be determined by a qualified healthcare professional. Always follow the instructions provided with your prescribed product and seek emergency assistance for severe or rapidly worsening symptoms.